Desialylation of peripheral blood mononuclear cells promotes growth of HIV-1

Virology

Volumn 228, Issue 2, 1997, Pages 123-131

  Stamatos, Nicholas M ^a   Gomatos, Peter J ^a   Cox, Josephine ^b   Fowler, Arnold ^b   Dow, Nancy ^c   Wohlhieter, John A ^a   Cross, Alan S ^a  

^a WALTER REED ARMY INSTITUTE OF RESEARCH   (United States)

^b SRA Technologies Inc   (United States)

^c WALTER REED ARMY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; LYSOZYME; SIALIDASE;

ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; MONOCYTE; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION; VIROGENESIS;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 0031575511     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1006/viro.1996.8373     Document Type: Article

References (39)

1. Boog C. J. P., Neefjes J. J., Boes J., Ploegh H. L., Melief C. J. M. Specific immune responses restored by alteration in carbohydrate chains of surface molecules on antigen-presenting cells. Eur. J. Immunol. 19:1989;537-542.
2. Carr S. A., Hemling M. E., Folena-Wasserman G., Sweet R. W., Anumula K., Barr J. R., Huddleston M. J., Taylor P. Protein and carbohydrate structural analysis of a recombinant soluble CD4 receptor by mass spectrometry. J. Biol. Chem. 264:1989;21286-21295.
3. Cullen B. R., Greene W. C. Regulatory pathways governing HIV-1 replication. Cell. 58:1989;423-426.
4. Cyster J. G., Shotton D. M., Williams A. F. The dimensions of the T lymphocyte glycoprotein leukosialin and identification of linear protein epitopes that can be modified by glycosylation. EMBO J. 10:1991;893-902.
5. Fogel M., Altevogt P., Schirrmacher V. Metastatic potential severely altered by changes in tumor cell adhesiveness and cell-surface sialylation. J. Exp. Med. 157:1983;371-376.
6. Gendelman H. E., Friedman R. M., Joe S., Baca L. M., Turpin J. A., Dveksler G., Meltzer M. S., Dieffenbach C. A selective defect of interferon alpha production in human immunodeficiency virus-infected monocytes. J. Exp. Med. 172:1990;1433-1442.
7. Gorczyca W., Wieczorek Z., Lisowski J. Cell surface sialic acid affects immunoglobulin binding to macrophages. FEBS Lett. 259:1989;99-102.
8. +. J. Immunol. 142:1989;773-780.
9. Hildreth J. E. K., Orentas R. J. Involvement of a leukocyte adhesion receptor (LFA-1) in HIV-induced syncytium formation. Science. 244:1989;1075-1078.
10. Homsy J., Meyer M., Tateno M., Clarkson S., Levy J. A. The Fc and not CD4 receptor mediates antibody enhancement of HIV infection in human cells. Science. 244:1989;1357-1359.
11. Hunig T. The role of accessory cells in polyclonal T cell activation II. Induction of interleukin 2 responsiveness requires cell-cell contact. Eur. J. Immunol. 13:1983;596-601.
12. Kabat D., Kozak S. L., Wehrly K., Chesebro B. Differences in CD4 dependence for infectivity of laboratory-adapted and primary patient isolates of human immunodeficiency virus type 1. J. Virol. 68:1994;2570-2577.
13. +. J. Virol. 64:1990;3399-3406.
14. Khan A. A., Steiner J. P., Snyder S. H. Plasma membrane isositol 1,4,5-triphosphate receptor of lymphocytes: Selective enrichment in sialic acid and unique binding specificity. Proc. Natl. Acad. Sci. USA. 89:1992;2849-2853.
15. Kinter A. L., Poli G., Fox L., Hardy E., Fauci A. S. HIV replication in IL-2-stimulated peripheral blood mononuclear cells is driven in an autocrine/paracrine manner by endogenous cytokines. J. Immunol. 154:1995;2448-2459.
16. Landolfi N. F., Leone J., Womack J. E., Cook R. G. Activation of T lymphocytes results in an increase in H-2-encoded neuraminidase. Immunogenetics. 22:1985;159-167.
17. Landolfi N. F., Cook R. G. Activated T-lymphocytes express Class I molecules which are hyposialylated compared to other lymphocyte populations. Mol. Immunol. 23:1986;297-309.
18. Langhoff E., Kalland K. H., Haseltine W. A. Early molecular replication of human immunodeficiency virus type 1 in cultured-blood-derived T helper dendritic cells. J. Clin. Invest. 91:1993;2721-2726.
19. Layne S. P, Spouge J. L., Dembo M. Quantifying the infectivity of human immunodeficiency virus. Proc. Natl. Acad. Sci. USA. 86:1989;4644-4648.
20. Lefebvre J. C., Giordanengo V., Doglio A., Cagnon L., Breittmayer J. P., Peyron J. F., Lesimple J. Altered sialylation of CD45 in HIV-1-infected T lymphocytes. Virology. 199:1994a;265-274.
21. Lefebvre J. C., Giordanengo V., Limouse M., Doglio A., Cucchiarini M., Monpoux F., Mariani R., Peyron J. F. Altered glycosylation of leukosialin, CD43, in HIV-1-infected cells of the CEM line. J. Exp. Med. 180:1994b;1609-1617.
22. Pantaleo G., Graziosi C., Demarest J. F., Butini L., Montroni M., Fox C. H., Orenstein J. M., Kotler D. P., Fauci A. S. HIV infection is active and progressive in lymphoid tissue during the clinically latent stage of disease. Nature. 362:1993;355-358.
23. Pope M., Betjes M. G. H., Romani N., Hirmand H., Cameron P. U., Hoffman L., Gezelter S., Schuler G., Steinman R. M. Conjugates of dendritic cells and memory T lymphocytes from skin facilitate productive infection with HIV-1. Cell. 78:1994;389-398.
24. Ramilo O., Bell K. D., Uhr J. W., Vitetta E. S. Role of CD25+ and CD25- T cells in acute HIV infection in vitro. J. Immunol. 150:1993;5202-5208.
25. Remold-O'Donnell E., Kenney D. U., Parkman R., Cairns L., Savage B., Rosen F. S. Characterization of a human lymphocyte surface sialoglycoprotein that is defective in Wiskott-Aldrich syndrome. J. Exp. Med. 159:1984;1705-1723.
26. Spouge J. L. Statistical analysis of sparse infection data and its implications for retroviral treatment trials in primates. Proc. Natl. Acad. Sci. USA. 89:1992;7581-7585.
27. Springer T. A. Adhesion receptors of the immune system. Nature. 346:1990;425-434.
28. M1M1. J. Immunol. 139:1987;2123-2129.
29. Taira S., Nariuchi H. Possible role of neuraminidase in activated T cells in the recognition of allogeneic Ia. J. Immunol. 141:1988;440-446.
30. Takeda A. Sialylation patterns of lymphocyte function-associated antigen 1 (LFA-1) differ between T and B lymphocytes. Eur. J. Immunol. 17:1987;281-286.
31. Takeda A., Tuazon C. U., Ennis F. A. Antibody-enhanced infection by HIV-1 via Fc receptor-mediated entry. Science. 242:1988;580-583.
32. Usuki S., Hoops P., Sweeley C. C. Growth control of human foreskin fibroblasts and inhibition of extracellular sialidase activity by 2-deoxy-2,3-dehydro-N. J. Biol. Chem. 263:1988;10595-10599.
33. Van der Horst G. T. J., Mancini G. M. S., Brossmer R., Rose U., Verheijen F. W. Photoaffinity labeling of a bacterial sialidase with an aryl azide derivative of sialic acid. J. Biol. Chem. 265:1990;10801-10804.
34. Veh R. W., Schauer R. Interaction of human brain neuraminidase with tritium-labeled gangliosides. Enzymes of Lipid Metabolism. 1978;. p. 447-462.
35. Wahl L. M., Katona I. M., Wilder R. L., Winter C. C., Haraoui B., Scher I., Wahl S. Isolation of human mononuclear cell subsets by counterflow centrifugal elutriation (CCE). I. Characterization of B-lymphocyte, T-lymphocyte, and monocyte-enriched fractions by flow cytometric analysis. Cell. Immunol. 85:1984;373-383.
36. +in vitro. Science. 234:1986;1563-1566.
37. Warren L. J. The thiobarbituric acid assay of sialic acids. J. Biol. Chem. 234:1959;1971-1975.
38. Zack J. A., Arrigo S. J., Weitsman S. R., Go A. S., Haislip A., Chen I. S. Y. HIV-1 entry into quiescent primary lymphocytes: Molecular analysis reveals a labile, latent viral structure. Cell. 61:1990;213-222.
39. Zack J. A., Haislip A. M., Krogstad P., Chen I. S. Y. Incompletely reverse-transcribed human immunodeficiency virus type 1 genomes in quiescent cells can function as intermediates in the retroviral life cycle. J. Virol. 66:1992;1717-1725.